PCOS Healthcare Trends · Evergreen explainer
How PCOS/PMOS is actually diagnosed: the 2-of-3 rule, explained
Many women arrive at a first appointment expecting one test that answers the question. There isn’t one. PCOS — now called PMOS — is diagnosed by a pattern: a clinician looks for two of three features, and only after checking that something else is not causing the same picture. This piece walks through that rule in plain language, so you can follow what a workup is doing and spot when one feels rushed.
The rule, in one sentence
In adults, the framework doctors are pointed to — the Rotterdam framework, kept in the 2023 International Evidence-based Guideline — asks whether at least two of these three are present:
- Irregular ovulation — periods that come rarely, unpredictably, or not at all, in a pattern that suggests eggs are not being released regularly.
- Androgen excess — signs on the body, such as excess hair growth, hormonal acne, or scalp hair thinning, and/or higher androgen levels on blood work. Our glossary explains androgens and related terms in plain language.
- A polycystic ovary pattern — on ultrasound, one ovary showing many small follicles (the guideline threshold in adults is 20 or more follicles in at least one ovary, or an ovarian volume of 10 mL or more), or — in adults only — a raised anti-Müllerian hormone (AMH) level used instead of the ultrasound for this one part of the rule.
Two are enough. One is not. And none of the three, on its own, makes the diagnosis.
Why “after ruling other things out” comes first
PCOS/PMOS is described by clinicians as a diagnosis of exclusion, which can sound like a delay tactic. It is the opposite: it is the careful part. Several other conditions can produce irregular periods or androgen signs — thyroid problems and a high prolactin level are two commonly named examples, and clinicians also consider other hormone conditions depending on the picture. A workup that skips that step risks giving the right label to the wrong cause, and then following the wrong problem for years. If a visit ends with a label but no discussion of what else was considered, that is a fair thing to ask about.
The shortcut the guideline itself allows
If an adult already has both irregular cycles and androgen excess, the guideline says an ultrasound is not needed to make the diagnosis — the two features already meet the rule. The scan or AMH becomes important mainly when only one of those two is present, and the third feature would be the deciding one. That is also why two women can both be diagnosed correctly and have had quite different workups.
Three things that are not a diagnosis on their own
- An ultrasound picture alone. Many women without this condition have ovaries that look polycystic, and many women with the condition do not show that picture at all. The scan supplies, at most, one of the three features.
- An AMH result alone. Since the 2023 guideline update, AMH can stand in for the ultrasound in adults to describe that ovary pattern. The guideline and reviews of it are explicit that AMH is not a stand-alone PCOS test — it replaces one part of the rule, not the whole rule — and there is no single universal AMH cut-off that fits every lab and every person.
- A symptom alone. Acne, weight change, irregular periods, or excess hair each have many possible causes. Symptoms are where a workup starts, not where it ends.
Why teenagers are handled differently
The guideline is extra careful with adolescents. In teens, both irregular cycles (judged against how long it has been since the first period) and androgen excess are required, and ultrasound and AMH are not used for this diagnosis in that age group — partly because ovary pictures that look polycystic are common in normal teen development. A slower, watch-and-revisit approach in a teenager is the guideline working as intended, not a dismissal.
What a complete workup usually includes
Details vary, but a thorough first workup generally covers:
- A history: when periods started, how often they come now, and how that has changed; skin and hair changes over time; and family history.
- A physical check, which may include blood pressure and a look at skin and hair patterns.
- Blood work chosen by the clinician to look at androgen levels and to rule out look-alike causes — the exact panel is a clinical choice, not a fixed list.
- Ultrasound or, in adults, AMH — only when that third feature is actually needed to apply the rule, as described above.
- A conversation about the wider picture the new PMOS name points to: metabolic health, mood, sleep, and fertility timing, and what follow-up screening looks like over time. Those topics have their own pages in this section.
Bringing a simple timeline helps more than most people expect: the dates of recent periods, when symptoms first appeared, and any prior lab or ultrasound reports. It turns “my periods are irregular” into a pattern a clinician can apply the rule to.
What this means when you are finding care
Diagnosis sits mainly with primary care clinicians, OB-GYNs, and endocrinologists, and fertility-focused questions often involve a reproductive endocrinologist. Whoever you see, the useful signal is process, not speed: a clinician who explains which two features they are counting, what they ruled out, and what remains uncertain is doing the work the guideline describes. You can search the directory for PCOS/PMOS-focused providers, browse by state — for example, the Florida listings page — and use the plain-language glossary to decode terms like AMH and androgen before or after a visit.
Questions worth asking your provider
- Which two of the three features are you counting in my case — and which one did we not find, or not need?
- What other conditions did you rule out, and with what tests or history?
- Do I need an ultrasound, an AMH test, both, or neither — and why in my case?
- If my picture does not meet the rule yet, what would you re-check, and when?
- Does my follow-up include metabolic screening, or only cycle tracking?
Sources
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome — diagnostic recommendations table, Journal of Clinical Endocrinology & Metabolism, 2023 — read the guideline recommendations
- The guideline program’s home at Monash University — Monash Centre for Health Research and Implementation — PCOS
- Federal overview of the condition and how it is diagnosed — NICHD — PCOS topic page
- Review of AMH as part of diagnosis after the 2023 update (2024) — Utility of serum AMH measurement as part of PCOS diagnosis, PMC
Looking for care? Find a PCOS/PMOS-focused provider or browse by state.
This article is general information published by the PMOS Directory. It is not medical advice and is not a substitute for professional medical advice, diagnosis, or treatment. It does not describe what any treatment does for any person, and it is not a recommendation for or against any treatment, product, or provider. Always seek the advice of your physician or other qualified health provider with any questions about a medical condition. If this is an emergency, call 911.